Chembio announces u.s. commercial launch of diagnostic tool to differentiate covid-19 and flu

In-licensed rapid point-of-care test available for use in detecting covid-19 antigens, flu a and flu b from a single patient sample in 15 minutes in-licensed rapid point-of-care test available for use in detecting covid-19 antigens, flu a and flu b from a single patient sample in 15 minutes
CEMI Ratings Summary
CEMI Quant Ranking